MedTrace Logo

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00318422 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1041

Last updated 2017-01-25

No results posted yet for this study

Summary

This trial is conducted globally (the United States of America excepted). This trial is designed to show the effect of treatment with liraglutide when added to existing glimepiride therapy and to compare this to both glimepiride monotherapy and to rosiglitazone as add-on therapy to glimepiride.

Conditions

Interventions

DRUG

liraglutide

DRUG

rosiglitazone

DRUG

glimepiride

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • Argentina
  • Australia
  • Brazil
  • Bulgaria
  • Croatia
  • Czechia
  • Finland
  • France
  • Greece
  • India
  • Israel
  • Italy
  • Malaysia
  • Philippines
  • Poland
  • Romania
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318422 on ClinicalTrials.gov